Farrah Fawcett was personally invested in the fight against anal cancer and other forms of cancers, as well. Because of this, the principles of the Farrah Fawcett Foundation have joined forces with Stand up to Cancer to fund a much-needed grant for a new HPV translational team grant. This is particularly critical as HPV (Human Papillomavirus) causes 5% of all cancers, the world over.
“We are very pleased to continue Farrah’s legacy by supporting this important scientific initiative.”
Alana Stewart, CEO of the Farrah Fawcett Foundation
The call for a research team was placed in 2013 and eight finalists were invited to submit a full proposal. Of those proposals, the AACR recommended funding for the Reinherz and Haddad team. The team will create new vaccines and other immunotherapeutic approaches, which provide a cancer-killing immunity. These treatments are for HPV-associated cancers, to include cancers of the anus, cervix and head and neck.
The focus is on patients with a HPV-driven cancer who had relapsed, following an initial therapy. These patients would not normally have many therapeutic options, even in today's times. A new and targeted approach could improve the outcome for these particular people.
The project will begin in July of this year and the AACR will administer the grant and act as an overseer, to ensure a certain progress.